Evidence-Based Complementary and Alternative Medicine

Complementary and Alternative Therapies for Liver Diseases 2014


Publishing date
13 Feb 2015
Status
Published
Submission deadline
26 Sep 2014

Lead Editor

1Sichuan University, Chengdu, China

2Suez Canal University, Ismailia, Egypt


Complementary and Alternative Therapies for Liver Diseases 2014

Description

Liver disease is a general term for any damage that reduces the functioning of the liver. It indicates any disease or disorder that causes the liver to function improperly or cease functioning. In recent years, complementary and alternative therapies gain popularity worldwide and have been used in a variety of diseases including those of the liver. However, their efficacy, safety, and mechanisms of action remain insufficiently understood and even controversial. Therefore, there is an urgent need for clarifying their efficacy, quality assurance, and reproducibility. Moreover, definite proof of their efficacy in liver diseases is scarce.

We invite authors to contribute original research and review articles that will stimulate the exertion to explore the field of complementary and alternative medicine for liver diseases by basic research, clinical practice, and clinical research to improve the efficacy of these therapies. In this special issue, we particularly take an interest in manuscripts that evaluate and discuss the rationale, methods, preliminary mechanism, clinical practice guideline, or expert consensus for complementary and alternative therapies in liver diseases.

Potential topics include, but are not limited to:

  • Recent developments in complementary and alternative therapies in liver diseases
  • Ex vivo and in vivo studies related to the treatment of liver diseases by the complementary and alternative therapies
  • Randomized controlled clinical trials with well-selected end points to assess the role of a therapy for liver diseases
  • Prevention of a liver disease by complementary and alternative medicine
  • Curative therapy and prevention of recurrence using antiviral therapy for prevention of postoperative recurrence of liver cancer
  • Combination use of conventional and alternative methods in treatment for liver diseases
  • Clinical trial protocols for alternative treatment of liver diseases
  • Evidence supporting the use of alternative treatment of liver diseases
  • Safety, licensing regulations, and pharmacovigilance regarding alternative treatment of liver diseases
  • Herbs-induced autoimmune-like liver injury

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 476431
  • - Editorial

Complementary and Alternative Therapies for Liver Diseases 2014

Yong-Song Guan | Qing He | Mohammad Ahmad Al-Shatouri
  • Special Issue
  • - Volume 2015
  • - Article ID 238495
  • - Research Article

Dynamical Regulation Analysis Identifies Molecular Mechanisms of Fuzheng-Huayu Formula against Hepatitis B-Caused Liver Cirrhosis

Qi-Long Chen | Yi-Yu Lu | ... | Shi-Bing Su
  • Special Issue
  • - Volume 2015
  • - Article ID 125659
  • - Review Article

Curative Effects of Fuzheng Huayu on Liver Fibrosis and Cirrhosis: A Meta-Analysis

Shu Dong | Qi-Long Chen | Shi-Bing Su
  • Special Issue
  • - Volume 2015
  • - Article ID 675270
  • - Research Article

Integrated Treatment of Aqueous Extract of Solanum nigrum-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells

Chien-Kai Wang | Yi-Feng Lin | ... | Chun-Chao Chang
  • Special Issue
  • - Volume 2015
  • - Article ID 824185
  • - Review Article

Plants Consumption and Liver Health

Yong-Song Guan | Qing He
  • Special Issue
  • - Volume 2015
  • - Article ID 171356
  • - Research Article

Huaier Aqueous Extract Induces Hepatocellular Carcinoma Cells Arrest in S Phase via JNK Signaling Pathway

Chengshuo Zhang | Jialin Zhang | ... | Yongfeng Liu
  • Special Issue
  • - Volume 2015
  • - Article ID 715638
  • - Research Article

Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease

Yun-liang Wang | Li-juan Liu | ... | Jun-xiang Li
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate26%
Submission to final decision70 days
Acceptance to publication37 days
CiteScore2.010
Impact Factor1.984
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.